Clarion News

Clarion is pleased to announce that Alyssa Trigger has been promoted to principal. Alyssa has spent nearly 10 years in the life sciences industry and has developed a deep knowledge of commercialization strategy and what it takes for pharmaceutical and biotechnology companies to be successful in today’s markets. At Clarion, she has supported a wide range of strategic initiatives from opportunity assessments and new product launch planning to Medical and KOL engagement strategy. In addition, she has experience in corporate and BD&L strategy, performance optimization strategies, and business process design.

Alyssa has contributed to the growth of Clarion’s new enterprise commercialization practice by supporting emerging biopharma companies preparing to commercialize their first asset. She has led numerous teams that worked as an extension of client leadership to envision the opportunity for their company and products as well as to define strategies, operational plans, and organizational scale-up and investment requirements that enable commercialization success.

“Alyssa’s ability to understand the nuances of each client, market, and product situation and integrate her deep knowledge of commercialization strategy provides unique value to our clients,” shares Bart Lombardi, Clarion managing member and founder. “Beyond her work with clients, she is also a leader internally and a role model for newer members of our firm. We are excited for her continued growth and development as she joins the Leadership Team.”

Prior to joining Clarion, Alyssa spent nearly four years developing medical devices as a research and development engineer with Johnson & Johnson. She holds a Master of Engineering Management degree from Duke University and graduated with a BS in biomedical engineering, magna cum laude, from Boston University.